Be the catalyst for change and experience the future of bioprocessing. Slash biologics development costs, supercharge your pipeline, and deliver transformative therapies with precision, quality, and ...

In the mRNA vaccine maker’s 2024 Shareholder Letter, CEO Stéphane Bancel reflected upon the company’s second year manufacturing and distributing vaccines for COVID-19, admitting that sales in the US ...

The world has reached another mile marker on the long and arduous road to eliminating human immunodeficiency virus (HIV) as a public-health threat. In June 2021, United Nations (UN) member states ...

Zuwei Jin, VP of Business Development at LISURE explains the advantages of the M++ system at BioProcess International US West 2025 in San Diego, CA. M++ is a pilot-scale modular benchtop system that ...

On the cover: an artist’s rendering of antibody molecules with linker–toxin payloads attached. HTTPS://STOCK.ADOBE.COM Antibody-conjugate technologies have been pushed out of the limelight somewhat in ...

Under the terms of the agreement, Boehringer’s ADC arm NBE Therapeutics (acquired for €1.18 billion ($1.20 billion) in 2020) will use Synaffix’s GlycoConnect, HydraSpace, and toxSYN technologies for ...

In the 24th year of this millennium, the biopharma sector navigated seismic shifts, from legislative challenges and technological advancements to restructuring and landmark acquisitions. Together, ...

Be the catalyst for change and experience the future of bioprocessing. Slash biologics development costs, supercharge your pipeline, and deliver transformative therapies with precision, quality, and ...

A significant challenge for TFF operators is an overreliance on vessel concentration estimates and upfront calculations, instead of real-time concentration data. In an attempt to maintain accuracies, ...

The term gene therapy (GT) encompasses a range of strategies for modifying or influencing genetic information either to treat or to prevent disease. GTs include both systems that work by introducing, ...

Be the catalyst for change and experience the future of bioprocessing. Slash biologics development costs, supercharge your pipeline, and deliver transformative therapies with precision, quality, and ...

BIOPROCESSING MASTERED: Unlock commercial success for mAbs, biologics, and ATMPs. From molecule to market, discover cutting-edge strategies to maximize efficiency, drive innovation, and ensure ...